{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:41Z","timestamp":1787026661365,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    The Zika virus (ZIKV) protease is an attractive drug target for the design of novel inhibitors to control the ZIKV infection. As the protease substrate-binding site contains acidic residues, inhibitors with basic residues can be beneficial for the inhibition of protease activities. Molecular dynamics (MD) simulation and molecular mechanics with generalized Born and surface area solvation (MM\/GBSA) techniques are employed herein to design potent peptide inhibitors and to understand the nature of the basic residues that can potentially stabilize the acidic residues of the protease substrate-binding site. It is found that the inclusion of K, R, and K at P1, P2, and P3 positions, respectively, and Y at the P4 position (YKRK) would generate a highly stable tetrapeptide-protease complex with a \u0394G\n                    <jats:sub>bind<\/jats:sub>\n                    of ~ \u221280 kcal\/mol. We have also shown that the C-terminal extension of this and the second most stable tetrapeptide (YRRR) with small polar residues, such as S and T would generate even more stable hexapeptide-protease complexes. The modes of interactions of these inhibitors are discussed in detail, which are in agreement with earlier experimental studies. Thus, this study is expected to aid in the design of novel antiviral drugs against the ZIKV.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2022.921060","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:17:34Z","timestamp":1657109854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["C-Terminal Extended Hexapeptides as Potent Inhibitors of the NS2B-NS3 Protease of the ZIKA Virus"],"prefix":"10.3389","volume":"9","author":[{"given":"Suyash","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihar R.","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1139\/cjm-2019-0331","article-title":"Zika virus: an emerging challenge to public health worldwide","volume":"66","author":"Sharma","year":"2020","journal-title":"Can J Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e3025","DOI":"10.7759\/cureus.3025","article-title":"Zika virus: a review of literature","volume":"10","author":"Agumadu","year":"2018","journal-title":"Cureus."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with Zika virus infection in Colombia","volume":"375","author":"Parra","year":"2016","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(16)00644-9","article-title":"Acute myelitis due to Zika virus infection","volume":"387","author":"Mecharles","year":"2016","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.13.30181","article-title":"Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia","volume-title":"Euro Surveill.","author":"Besnard","year":"2016"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.3390\/ijerph17113806","article-title":"Zika virus and the risk of developing microcephaly in infants: a systematic review","volume":"17","author":"Antoniou","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12978-017-0285-6","article-title":"Zika virus infection in pregnancy: a systematic review of disease course and complications","volume":"14","author":"Chibueze","year":"2017","journal-title":"Reprod Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1101\/gad.298216.117","article-title":"How does Zika virus cause microcephaly?","volume":"31","author":"Wen","year":"2017","journal-title":"Genes Dev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1038\/s41467-020-16754-z","article-title":"Metabolic reprogramming by Zika virus provokes inflammation in human placenta","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"i657","DOI":"10.1136\/bmj.i657","article-title":"Zika virus is a global public health emergency, declares WHO","volume":"352","author":"Gulland","year":"2016","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1021\/acs.jmedchem.9b00775","article-title":"Drugs for the treatment of Zika virus infection","volume":"63","author":"Bernatchez","year":"2020","journal-title":"J Med Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jix464","article-title":"Zika virus vaccine development","volume":"216","author":"Morabito","year":"2017","journal-title":"J Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","article-title":"Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease","volume":"3","author":"Kumar","year":"2018","journal-title":"ACS Omega."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S935","DOI":"10.1093\/infdis\/jix515","article-title":"Zika virus structure, maturation, and receptors","volume":"216","author":"Sirohi","year":"2017","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/v14010044","article-title":"Potential role of flavivirus NS2B-NS3 proteases in viral pathogenesis and anti-flavivirus drug discovery employing animal cells and models: a review","volume":"14","author":"Wahaab","year":"2022","journal-title":"Viruses."},{"key":"B16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-981-10-8727-1_10","article-title":"The structure of the Zika virus protease, NS2B\/NS3(pro)","volume":"1062","author":"Hilgenfeld","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1038\/ncomms13410","article-title":"Structure of the NS2B-NS3 protease from Zika virus after self-cleavage","volume":"7","author":"Phoo","year":"2016","journal-title":"Nat Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1021\/acschembio.8b00508","article-title":"The unique cofactor region of Zika Virus NS2B-NS3 Protease facilitates cleavage of key host proteins","volume":"9","author":"Hill","year":"2018","journal-title":"ACS Chem Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"126965","DOI":"10.1016\/j.bmcl.2020.126965","article-title":"Inhibitors of the Zika virus protease NS2B-NS3","volume":"30","author":"Voss","year":"2020","journal-title":"Bioorg Med Chem Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.1038\/s41598-020-65489-w","article-title":"Zika Virus NS3 protease pharmacophore anchor model and drug discovery","volume":"10","author":"Pathak","year":"2020","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","article-title":"Zika virus protease: an antiviral drug target","volume":"25","author":"Kang","year":"2017","journal-title":"Trends Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12250-013-3390-x","article-title":"The flavivirus protease as a target for drug discovery","volume":"28","author":"Brecher","year":"2013","journal-title":"Virol Sin."},{"key":"B23","article-title":"Structural insights into the inhibition of Zika virus NS2B-NS3 protease by a small-molecule inhibitor","volume-title":"Structure","author":"Li","year":"2018"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.2174\/13816128113199990633","article-title":"Drug design for flavivirus proteases: what are we missing?","volume":"20","author":"Poulsen","year":"2014","journal-title":"Curr Pharm Des."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/biomedicines9081044","article-title":"Structure and dynamics of Zika virus protease and its insights into inhibitor design","volume":"9","author":"Li","year":"2021","journal-title":"Biomedicines."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0180632","DOI":"10.1371\/journal.pone.0180632","article-title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants","volume":"12","author":"Roy","year":"2017","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","article-title":"Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antiviral Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science."},{"key":"B29","article-title":"Structural dynamics of Zika virus NS2B-NS3 protease binding to dipeptide inhibitors","volume-title":"Structure","author":"Li","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2018.10.006","article-title":"Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors","volume":"160","author":"Phoo","year":"2018","journal-title":"Antiviral Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"15683","DOI":"10.1039\/D0CP02254C","article-title":"Intermolecular interactions of cn-716 and acyl-KR-aldehyde dipeptide inhibitors against Zika virus","volume":"22","author":"Campos","year":"2020","journal-title":"Phys Chem Chem Phys."},{"key":"B32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsmedchemlett.8b00535","article-title":"De novo discovery of nonstandard macrocyclic peptides as noncompetitive inhibitors of the Zika virus NS2B-NS3 protease","volume":"10","author":"Nitsche","year":"2019","journal-title":"ACS Med Chem Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/cmdc.202000237","article-title":"Structure-based macrocyclization of substrate analogue NS2B-NS3 protease inhibitors of Zika, West Nile and dengue viruses","volume":"15","author":"Braun","year":"2020","journal-title":"Chem Med Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2018.06.062","article-title":"Characterization of molecular interactions between Zika virus protease and peptides derived from the C-terminus of NS2B","volume":"503","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2022.2045223","article-title":"Structures and dynamics of peptide and peptidomimetic inhibitors bound to the NS2B-NS3 protease of the ZIKA virus","volume":"3","author":"Pant","year":"2022","journal-title":"J Biomol Struct Dyn."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28766","DOI":"10.1074\/jbc.M500588200","article-title":"Functional profiling of recombinant NS3 protease from all four sterotypes of Dengu virus using tetrapeptide and octapeptide substrate libraries","volume":"280","author":"Li","year":"","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/1873-3468.12443","article-title":"et al. Substrate profiling of Zika virus NS2B-NS3 protease","volume":"590","author":"Gruba","year":"2016","journal-title":"FEBS Letters."},{"key":"B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.peptides.2013.12.002","article-title":"et al. A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile Virus NS2B\/NS3 protease using C-terminal agmatine dipeptides","volume":"52","author":"Ang MJ Li","year":"2014","journal-title":"Peptides."},{"key":"B39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12551-019-00508-3","article-title":"Proteases from dengue, West Nile and Zika viruses as drug targets","volume":"11","author":"Nitsche","year":"2019","journal-title":"Biophys. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1126\/science.aai9309","article-title":"Kang C,et al. Crystal structure of the unlinked NS2B-NS3 protease from Zika virus","volume":"354","author":"Zhang","year":"2016","journal-title":"Science."},{"key":"B41","volume-title":"The PyMOL Molecular Graphics System, Version 1.2r3pre","year":""},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2021.1883112","article-title":"Artificially expanded genetic information systems (AEGISs) as potent inhibitors of the RNA-dependent RNA polymerase of SARS-CoV-2","volume-title":"J Biomol Struct Dyn","author":"Jena","year":"2021"},{"key":"B43","doi-asserted-by":"publisher","first-page":"106012","DOI":"10.1016\/j.ejps.2021.106012","article-title":"Jena NR. Inhibition of the RNA-dependent RNA polymerase of the SARS-CoV-2 by short peptide inhibitors, European","volume":"167","author":"Pant","year":"2021","journal-title":"J Pharm Sci."},{"key":"B44","volume-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing. Tampa, Florida","year":"2006"},{"key":"B45","volume-title":"Maestro-Desmond Interoperability Tools.","year":"2021"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theory Comput."},{"key":"B47","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1063\/1.2018637","article-title":"Structural properties of water: comparison of the SPC, SPCE, TIP4P, and TIP5P models of water","volume":"123","author":"Zielkiewicz","year":"2005","journal-title":"J Chem Phys."},{"key":"B48","doi-asserted-by":"publisher","first-page":"040009","DOI":"10.1063\/1.4995124","article-title":"Limited memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) method for the parameter estimation on geographically weighted ordinal logistic regression model (GWOLR)","volume":"1868","author":"Saputro","year":"2017","journal-title":"AIP Conf Proc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1103\/PhysRevA.33.4253","article-title":"Canonical dynamics of the nose oscillator: stability, order, and chaos","volume":"33","author":"Posch","year":"1986","journal-title":"Phys Rev A Gen phys."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J Chem Phys."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1063\/1.470043","article-title":"Accuracy and efficiency of the particle mesh Ewald method","volume":"103","author":"Petersen","year":"1995","journal-title":"J Chem Phys."},{"key":"B52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jmgm.2019.08.001","article-title":"Binding recognition of substrates in NS2B\/NS3 serine protease of zika virus revealed by molecular dynamics simulations","volume":"92","author":"Nutho","year":"2019","journal-title":"J Mol Graph Model."},{"key":"B53","first-page":"1","volume-title":"Recent Advances in Inhibitors of Flavivirus NS2B-NS3 Protease From Dengue, Zika, and West Nile Viruses, Book: Vector-Borne Diseases and Treatment.","author":"F da Silva-J\u00fanior","year":"2018"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/prot.25809","article-title":"MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B\/NS3 protease","volume":"2019","author":"Ren","year":"2019","journal-title":"Proteins"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.921060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:17:44Z","timestamp":1657109864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.921060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":54,"alternative-id":["10.3389\/fmed.2022.921060"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.921060","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"921060"}}